NRX Pharmaceuticals Newsroom

NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital

Dow JonesDec 2 17:48

NRX Pharmaceuticals Price Target Raised to $45.00/Share From $44.00 by Ascendiant Capital

Dow JonesDec 2 17:48

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target

BenzingaNov 25 21:39

NRX Pharmaceuticals Analyst Ratings

BenzingaNov 25 21:38

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target

BenzingaNov 16 06:00

NRX Pharmaceuticals Analyst Ratings

BenzingaNov 16 05:59

EF Hutton Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $31

BenzingaOct 21 19:32

NRX Pharmaceuticals Analyst Ratings

BenzingaSep 13 01:58

HC Wainwright & Co. Maintains Buy on NRX Pharmaceuticals, Adjusts Price Target To $19 (1-10 Reverse Stock Split)

BenzingaAug 6 03:42

NRX Pharmaceuticals Analyst Ratings

BenzingaAug 6 03:40

NRX Pharmaceuticals Analyst Ratings

BenzingaJun 8 00:00

Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $43

BenzingaJun 8 00:00

Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100

TipRanksJan 23 03:09

Analysts Are Bullish on These Healthcare Stocks: HCA Healthcare (HCA), NRX Pharmaceuticals (NRXP)

TipRanksOct 24, 2023 21:50

H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)

TipRanksMay 25, 2023 18:15

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target

BenzingaMay 25, 2023 18:07

Ascendiant Remains a Buy on NRX Pharmaceuticals (NRXP)

TipRanksApr 7, 2023 16:20

NRX Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsFeb 3, 2023 01:21

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target

Benzinga Real-time NewsFeb 3, 2023 01:21

H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)

TipRanksFeb 3, 2023 01:20